Answers are grounded in this paper and cite their sources.
Tirzepatide use reduces asthma exacerbations in obese adults, indicating potential for broader treatment applications.
Summary Tirzepatide use was associated with fewer asthma exacerbations in obese adults without prior exacerbations. Findings are limited to a selective asthma population and require validation in broader cohorts.
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: